European Neuropsychopharmacology
Volume 20, Issue 10 , Pages 683-687 , October 2010

Levodopa and 3-OMD levels in Parkinson patients treated with Duodopa

  • A. Antonini

      Affiliations

    • Ist. Clinici Perfezionamento, Parkinson Institute, Milan, Italy
    • IRCCS San Camillo, Venezia, Italy
    • ,
  • G. Bondiolotti

      Affiliations

    • Dept. of Pharmacology, University of Milan, Milan, Italy
    • ,
  • F. Natuzzi

      Affiliations

    • Ist. Clinici Perfezionamento, Parkinson Institute, Milan, Italy
    • ,
  • S.R. Bareggi

      Affiliations

    • Dept. of Pharmacology, University of Milan, Milan, Italy
    • Corresponding Author InformationCorresponding author. Dept. of Pharmacology, University of Milan, Via Vanvitelli 32, 20129 Milano, Italy. Tel.: +39 02 5031 6946.

Received 9 February 2010 ,Revised 26 April 2010 ,Accepted 30 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0924-977X(10)00092-1

doi: 10.1016/j.euroneuro.2010.04.010

European Neuropsychopharmacology
Volume 20, Issue 10 , Pages 683-687 , October 2010

Article Tools

* Image Usage & Resolution